Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologist Lars Klareskog, MD, PhD, In the Spotlight

Gretchen Henkel  |  Issue: December 2014  |  December 1, 2014

In addition to his academic and research pursuits, Dr. Klareskog has been a vigorous participant in many national and international organizations. From 1995–2012 he was a member of the Karolinska’s Nobel Assembly; he has participated as a member of EULAR’s scientific committee; he has chaired and co-chaired the Scientific Board of the Swedish Rheumatism Association, a patient organization; and he has served on advisory boards of several pharmaceutical and biotechnology companies. He has been devoted to the development of international consortia in arthritis research.

Asked whether he took time off, he answers simply, “Rarely.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

A life in science, he explains, is “a privileged life that contains so many opportunities for exploration of different scientific and social cultures and so many opportunities to meet with engaged humans beings from all over the world. So ‘time off’ is not what you wish for as a scientist,” he says—“in particular when being married to an equally engaged and internationally active scientist.” Dr. Klareskog’s wife is Ingrid Lundberg, professor in the same department at the Karolinska.


Gretchen Henkel is a medical journalist based in California.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Klareskog L, Sandberg-Tragardh L, Rask L, et al. Chemical properties of human Ia antigens. Nature. 1977 Jan 20; 265(5591):248–251.
  2. Klareskog L, Forsum U, Scheynius A, et al., Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3632–3636.
  3. Klareskog L, Tjernlund U, Forsum U, et al. Epidermal Langerhans cells express Ia antigens. Nature. 1977 Jul 21;268(5617):248–250.
  4. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006 Jan;54(1):38–46.
  5. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis–a genome wide study. N Engl J Med. 2007 Sep 20;357(12):1199–1209.
  6. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009 Feb 21;373(9664):659–672.
  7. Amara K, Steen J, Murray F, et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med. 2013 Mar 11;210(3):445–455.
  8. Klareskog L, Gregersen PK, Huizinga TWJ. Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann Rheum Dis. 2010 Dec; 69(12):2062–2066.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsProfessional TopicsProfilesRheumatoid Arthritis Tagged with:CareerHenkelLeadershipRheumatoid arthritisrheumatologist

Related Articles

    Can Genetic Information Change the Clinical Care of Rheumatology Patients?

    February 15, 2017

    WASHINGTON, D.C.—Calling it an extremely challenging topic, Peter K. Gregersen, MD, professor and head, Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute, Manhasset, N.Y., said the current role of genetics in clinical practice is less about how to use genetic information to care for patients and more about how providers and patients…

    EUnited to Cure

    April 1, 2007

    AutoCure brings together researchers across Europe to combat RA

    Rheumatologists on the Move

    June 1, 2013

    Awards, appointments, and announcements in the world of rheumatology

    EULAR 2012: Rewards in Risk Factor Research

    September 5, 2012

    Investigations of infection and comorbidities offers hints to better understanding of rheumatoid arthritis.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences